BTRC and prostate carcinoma: Beta-transducin repeats-containing protein (βTrCP) is overexpressed in breast and prostate cancer and the underlying molecular mechanism is that βTrCP promotes tumorigenesis by promoting the degradation of metastasis suppressor 1 (MTSS1) protein by UPS.